Tirzepatide (Mounjaro) a dual GLP-1/GIP agonist licensed in the UK for type 2 diabetes and, following a positive NICE technology appraisal (TA1026), recommended for weight management in eligible adults within specialist services
Thats entirely your decision
For those struggling with weight loss or managing chronic conditions like obesity, type 2 diabetes, or high blood pressure, the Cosmetic Enhancement Center of New England offers effective solutions with GLP-1 medications at our locations in Portland, Falmouth, and Waterville, Maine
Shats, I
In addition, it was observed that use of any GLP-1 RA was associated with the risk of pancreatitis, and the signal strength of pancreatitis was ranked as follows: liraglutide (ROR, 32.67
Topical NSAIDs: For localized pain, topical NSAIDs like diclofenac gel might be an option